Literature DB >> 28710617

Steroid Bioconversions.

Marina V Donova1,2.   

Abstract

Steroid modifications by selected wild-type and engineered strains of microorganisms became an effective tool for the production of high-valued steroidal drugs and their precursors for the pharmaceutical industry. Some microorganisms are effective at the performance of sterol side-chain degradation, oxyfunctionalization of steroid core, and redox reactions at different positions of the steroid molecule. A number of bioprocesses using steroid-transforming microbial strains are well established on an industrial level. Although a range of biocatalytic methods has been developed, selection of suitable microorganisms, as well as creation of new engineered strains, is of great importance for generation of improved bioprocesses and production schemes for obtaining known and new metabolites with potent biological activity. The achievements in genetic and metabolic engineering of steroid-transforming strains in combination with novel approaches in the enzymatic and whole-cell biocatalysis provide a platform for highly effective and selective biotransformations.Here, we briefly review the current state and prospects in the field of microbial bioconversions with special attention to the application of molecular microbiology methods for the generation of new whole cell biocatalysts.

Entities:  

Keywords:  Bioconversion; Dehydrogenation; Hydroxylation; Microbial transformation; Phytosterol; Side-chain degradation; Steroid; Sterol catabolism; Whole-cell biocatalysis

Mesh:

Substances:

Year:  2017        PMID: 28710617     DOI: 10.1007/978-1-4939-7183-1_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  The unusual convergence of steroid catabolic pathways in Mycobacterium abscessus.

Authors:  Adam M Crowe; Jessica M C Krekhno; Kirstin L Brown; Jayesh A Kulkarni; Katherine C Yam; Lindsay D Eltis
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

2.  Efficient conversion of phytosterols into 4-androstene-3,17-dione and its C1,2-dehydrogenized and 9α-hydroxylated derivatives by engineered Mycobacteria.

Authors:  Xin Li; Tian Chen; Fei Peng; Shikui Song; Jingpeng Yu; Douanla Njimeli Sidoine; Xiyao Cheng; Yongqi Huang; Yijun He; Zhengding Su
Journal:  Microb Cell Fact       Date:  2021-08-16       Impact factor: 5.328

Review 3.  Rational development of mycobacteria cell factory for advancing the steroid biomanufacturing.

Authors:  Xin-Xin Wang; Xia Ke; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  World J Microbiol Biotechnol       Date:  2022-08-17       Impact factor: 4.253

4.  Further Studies on the 3-Ketosteroid 9α-Hydroxylase of Rhodococcus ruber Chol-4, a Rieske Oxygenase of the Steroid Degradation Pathway.

Authors:  Sara Baldanta; Juana María Navarro Llorens; Govinda Guevara
Journal:  Microorganisms       Date:  2021-05-29

Review 5.  New Insights on Steroid Biotechnology.

Authors:  Lorena Fernández-Cabezón; Beatriz Galán; José L García
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640

6.  Regio- and Stereoselective Steroid Hydroxylation at C7 by Cytochrome P450 Monooxygenase Mutants.

Authors:  Aitao Li; Carlos G Acevedo-Rocha; Lorenzo D'Amore; Jinfeng Chen; Yaqin Peng; Marc Garcia-Borràs; Chenghua Gao; Jinmei Zhu; Harry Rickerby; Sílvia Osuna; Jiahai Zhou; Manfred T Reetz
Journal:  Angew Chem Int Ed Engl       Date:  2020-05-25       Impact factor: 15.336

7.  Whole-genome and enzymatic analyses of an androstenedione-producing Mycobacterium strain with residual phytosterol-degrading pathways.

Authors:  Hongwei Wang; Shikui Song; Fei Peng; Fei Yang; Tian Chen; Xin Li; Xiyao Cheng; Yijun He; Yongqi Huang; Zhengding Su
Journal:  Microb Cell Fact       Date:  2020-10-02       Impact factor: 5.328

8.  Production of 11α-hydroxysteroids from sterols in a single fermentation step by Mycolicibacterium smegmatis.

Authors:  Carmen Felpeto-Santero; Beatriz Galán; José Luis García
Journal:  Microb Biotechnol       Date:  2021-03-04       Impact factor: 5.813

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.